No Data
BofA Securities Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $7
Sana Biotechnology Faces Uncertainty as Financial Struggles Threaten Future Operations
TD Cowen Maintains Sana Biotechnology(SANA.US) With Buy Rating
JMP Securities Upgrades Sana Biotechnology(SANA.US) to Buy Rating, Announces Target Price $5
H.C. Wainwright Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $11
Sana Biotechnology Shares Are Trading Lower. The Company Reported Q4 Financial Results.
Unlock the Full List
NewToOptions : afternoon father, I've been researching PACB and wanting your opinion on if you would place $2 short period calls at this price?
TheFather OP NewToOptions : My plan on this one is to sell 25% of my shares when it reaches 2.25 in order to lower my total cost. That will leave me to wait all the way to 3.50 with the remainder of my shares. That is my opinion, and thank you for asking. I wish you the best this week.